{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:23:05Z","timestamp":1785338585789,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2024 Hubei Provincial Natural Science Foundation Joint Fund for Innovation and Development Key Project","award":["2024AF0276"],"award-info":[{"award-number":["2024AF0276"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Polycystic ovarian syndrome (PCOS) is a frequently occurring disorder affecting reproductive and metabolic health. miR-338-3p is implicated in early follicular development. We aimed to investigate the expression of miR-338-3p in PCOS patients and its effects on proliferation and apoptosis of ovarian granulosa cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study included 100 healthy women and 110 women diagnosed with PCOS as participants. Reverse transcription quantitative PCR (RT-qPCR) was used to detect the expression of miR-338-3p and phosphatase and tensin homolog (PTEN), and receiver operating characteristic (ROC) was employed to evaluate the diagnostic efficacy of miR-338-3p. Cell proliferation and apoptosis were detected by Cell Counting Kit-8 (CCK-8) and flow cytometry. Pearson correlation analysis was used to assess the correlations between miR-338-3p and luteinizing hormone (LH), testosterone, or PTEN. The target relationship of miR-338-3p and PTEN was confirmed via dual-luciferase assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serum miR-338-3p was decreased in PCOS patients, and it was negatively correlated with both LH and testosterone. Downregulation of miR-338-3p inhibits the proliferation of ovarian granulosa cells and enhances cell apoptosis, whereas upregulation produces the opposite effect. PTEN inhibition subverted the inhibited proliferation and enhanced apoptosis regulated by miR-338-3p inhibitor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Reduced miR-338-3p levels have potential predictive value in distinguishing individuals with PCOS patients from normal population. Mechanistically, this microRNA regulates the PTEN gene to inhibit granulosa cell proliferation and promote apoptosis, thereby contributing to the pathological processes of PCOS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00498-1","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T07:06:09Z","timestamp":1752303969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reduced miR-338-3p contributes to polycystic ovarian syndrome by inhibiting proliferation and enhancing apoptosis"],"prefix":"10.1186","volume":"162","author":[{"given":"Lin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"498_CR1","doi-asserted-by":"publisher","first-page":"1035929","DOI":"10.3389\/fendo.2022.1035929","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye Y, Zhou CC, Hu HQ, Fukuzawa I, Zhang HL. Underlying mechanisms of acupuncture therapy on polycystic ovary syndrome: evidences from animal and clinical studies. Front Endocrinol (Lausanne). 2022;13:1035929.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"498_CR2","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-19-0197","volume":"159","author":"DA Dumesic","year":"2020","unstructured":"Dumesic DA, Hoyos LR, Chazenbalk GD, Naik R, Padmanabhan V, Abbott DH. Mechanisms of intergenerational transmission of polycystic ovary syndrome. Reproduction. 2020;159(1):R1\u201313.","journal-title":"Reproduction"},{"issue":"1","key":"498_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ecl.2020.10.005","volume":"50","author":"AM Valent","year":"2021","unstructured":"Valent AM, Barbour LA. Management of women with polycystic ovary syndrome during pregnancy. Endocrinol Metab Clin North Am. 2021;50(1):57\u201369.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"498_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","volume":"18","author":"H Zhao","year":"2021","unstructured":"Zhao H, Xing C, Zhang J, He B. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and Berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021;18(1):171.","journal-title":"Reprod Health"},{"issue":"32","key":"498_CR5","doi-asserted-by":"publisher","first-page":"e30006","DOI":"10.1097\/MD.0000000000030006","volume":"101","author":"J Zhao","year":"2022","unstructured":"Zhao J, Sui X, Shi Q, Su D, Lin Z. Effects of antioxidant intervention in patients with polycystic ovarian syndrome: A systematic review and meta-analysis. Med (Baltim). 2022;101(32):e30006.","journal-title":"Med (Baltim)"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"789939","DOI":"10.3389\/fendo.2021.789939","volume":"12","author":"G Zhou","year":"2021","unstructured":"Zhou G, Gu Y, Zhou F, Zhang H, Zhang M, Zhang G, et al. Adipocytes-Derived extracellular Vesicle-miR-26b promotes apoptosis of cumulus cells and induces polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:789939.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"498_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13018-025-05695-2","volume":"20","author":"J Xiang","year":"2025","unstructured":"Xiang J, Huang L, Qu C, Bao W, Wang W, Zhu X, et al. Serum miR-519d-3p and BMP2: potential early diagnostic markers and their mechanism in delayed fracture healing. J Orthop Surg Res. 2025;20(1):302.","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"498_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/19476035221114858","volume":"14","author":"G Li","year":"2023","unstructured":"Li G, Song Y. Cinnamaldehyde induces the expression of MicroRNA-1285-5p and MicroRNA-140-5p in chondrocytes to ameliorate the apoptosis and inflammatory response. Cartilage. 2023;14(3):375\u201385.","journal-title":"Cartilage"},{"issue":"3","key":"498_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/genes5030684","volume":"5","author":"AE Sorensen","year":"2014","unstructured":"Sorensen AE, Wissing ML, Salo S, Englund AL, Dalgaard LT. MicroRNAs related to polycystic ovary syndrome (PCOS). Genes (Basel). 2014;5(3):684\u2013708.","journal-title":"Genes (Basel)"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"967151","DOI":"10.3389\/fimmu.2022.967151","volume":"13","author":"W Tan","year":"2022","unstructured":"Tan W, Dai F, Yang D, Deng Z, Gu R, Zhao X, et al. MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome. Front Immunol. 2022;13:967151.","journal-title":"Front Immunol"},{"issue":"1","key":"498_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-022-00876-6","volume":"20","author":"J Cao","year":"2022","unstructured":"Cao J, Huo P, Cui K, Wei H, Cao J, Wang J, et al. Follicular fluid-derived Exosomal miR-143-3p\/miR-155-5p regulate follicular dysplasia by modulating Glycolysis in granulosa cells in polycystic ovary syndrome. Cell Commun Signal. 2022;20(1):61.","journal-title":"Cell Commun Signal"},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.12.007","volume":"256","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang S, Chen L, Huang X, Wang M, Ponikwicka-Tyszko D, et al. The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome. Transl Res. 2023;256:1\u201313.","journal-title":"Transl Res"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"1153960","DOI":"10.3389\/fgene.2023.1153960","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Han T, Wang Y, Gao J, Zhang J, Wu Y, et al. Association of Calpain10 polymorphisms with polycystic ovarian syndrome susceptibility: a systematic review and meta-analysis with trial sequential analysis. Front Genet. 2023;14:1153960.","journal-title":"Front Genet"},{"issue":"3","key":"498_CR14","doi-asserted-by":"publisher","first-page":"100538","DOI":"10.1016\/j.bj.2022.05.003","volume":"46","author":"M Farhadi-Azar","year":"2023","unstructured":"Farhadi-Azar M, Ghahremani M, Mahboobifard F, Noroozzadeh M, Yaghmaei P, Tehrani FR. Effects of Rosa Damascena on reproductive improvement, metabolic parameters, liver function and insulin-like growth factor-1 gene expression in estradiol valerate induced polycystic ovarian syndrome in Wistar rats. Biomed J. 2023;46(3):100538.","journal-title":"Biomed J"},{"issue":"6","key":"498_CR15","first-page":"e62611","volume":"16","author":"MP Pereira","year":"2024","unstructured":"Pereira MP, Jones S, Costin JM. Association of polycystic ovarian syndrome (PCOS) with vaginal Microbiome dysbiosis: A scoping review. Cureus. 2024;16(6):e62611.","journal-title":"Cureus"},{"key":"498_CR16","doi-asserted-by":"crossref","unstructured":"Dou L, Wang S, Sun L, Huang X, Zhang Y, Shen T et al. mir-338-3p mediates Tnf-A-Induced hepatic insulin resistance by targeting PP4r1 to regulate PP4 expression. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and Pharmacology. 2017;41(6):2419\u201331.","DOI":"10.1159\/000475912"},{"issue":"4","key":"498_CR17","first-page":"4129","volume":"18","author":"S Wang","year":"2018","unstructured":"Wang S, Li L, Chen X, Huang X, Liu J, Sun X, et al. miR\u2013338\u20133p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes. Mol Med Rep. 2018;18(4):4129\u201337.","journal-title":"Mol Med Rep"},{"issue":"1","key":"498_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13048-023-01258-3","volume":"16","author":"Z Xu","year":"2023","unstructured":"Xu Z, Zhang T, Hu J, Zhang J, Yang G, He J, et al. MicroRNA-338-3p helps regulate ovarian function by affecting granulosa cell function and early follicular development. J Ovarian Res. 2023;16(1):175.","journal-title":"J Ovarian Res"},{"issue":"5","key":"498_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/me.2014-1299","volume":"29","author":"C Jacovetti","year":"2015","unstructured":"Jacovetti C, Jimenez V, Ayuso E, Laybutt R, Peyot ML, Prentki M, et al. Contribution of intronic miR-338-3p and its hosting gene AATK to compensatory beta-Cell mass expansion. Mol Endocrinol. 2015;29(5):693\u2013702.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"498_CR20","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1172\/JCI64151","volume":"122","author":"C Jacovetti","year":"2012","unstructured":"Jacovetti C, Abderrahmani A, Parnaud G, Jonas JC, Peyot ML, Cornu M, et al. MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. J Clin Invest. 2012;122(10):3541\u201351.","journal-title":"J Clin Invest"},{"issue":"Suppl 5","key":"498_CR21","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/00005344-199322005-00005","volume":"22","author":"GM Rubanyi","year":"1993","unstructured":"Rubanyi GM, Kauser K, Graser T. Effect of Cilazapril and indomethacin on endothelial dysfunction in the aortas of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1993;22(Suppl 5):S23\u201330.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"498_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1159\/000358698","volume":"33","author":"W Long","year":"2014","unstructured":"Long W, Zhao C, Ji C, Ding H, Cui Y, Guo X, et al. Characterization of serum MicroRNAs profile of PCOS and identification of novel non-invasive biomarkers. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2014;33(5):1304\u201315.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.theriogenology.2022.08.019","volume":"192","author":"D Li","year":"2022","unstructured":"Li D, Li X, He H, Zhang Y, He H, Sun C, et al. miR-10a-5p inhibits chicken granulosa cells proliferation and Progesterone(P4) synthesis by targeting MAPRE1 to suppress CDK2. Theriogenology. 2022;192:97\u2013108.","journal-title":"Theriogenology"},{"issue":"7","key":"498_CR24","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.3390\/ijms13078514","volume":"13","author":"X Fu","year":"2012","unstructured":"Fu X, Tan D, Hou Z, Hu Z, Liu G. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3\u2019-UTR region of CyclinD1. Int J Mol Sci. 2012;13(7):8514\u201339.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"498_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3349\/ymj.2019.60.12.1146","volume":"60","author":"Q Niu","year":"2019","unstructured":"Niu Q, Liu Z, Gao J, Wang Q. MiR-338-3p enhances ovarian Cancer cell sensitivity to cisplatin by downregulating WNT2B. Yonsei Med J. 2019;60(12):1146\u201356.","journal-title":"Yonsei Med J"},{"issue":"1","key":"498_CR26","first-page":"151","volume":"6","author":"S Garciaz","year":"2023","unstructured":"Garciaz S, Miller T, Collette Y, Vey N. Targeting regulated cell death pathways in acute myeloid leukemia. Cancer Drug Resist (Alhambra Calif). 2023;6(1):151\u201368.","journal-title":"Cancer Drug Resist (Alhambra Calif)"},{"key":"498_CR27","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of Cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290.","journal-title":"Front Oncol"},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"9218113","DOI":"10.1155\/2022\/9218113","volume":"2022","author":"M Cao","year":"2022","unstructured":"Cao M, Bu C, Zhang J, Ren Y, Zhou G, Chen C, et al. Exosomal circular RNA hsa_circ_0046060 of umbilical cord mesenchymal stromal cell ameliorates glucose metabolism and insulin resistance in gestational diabetes mellitus via the miR-338-3p\/G6PC2 Axis. Int J Endocrinol. 2022;2022:9218113.","journal-title":"Int J Endocrinol"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1191759.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"498_CR31","doi-asserted-by":"publisher","first-page":"20774","DOI":"10.1038\/s41598-023-47809-y","volume":"13","author":"M Namli Kalem","year":"2023","unstructured":"Namli Kalem M, Anadol E, Kalem Z, Sezginer PY, Elmas C, Yilmaz C, et al. A rat study on the PTEN expression in ovarian tissue in PCOS and folliculogenesis. Sci Rep. 2023;13(1):20774.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"498_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-013-1673-z","volume":"380","author":"JX Ouyang","year":"2013","unstructured":"Ouyang JX, Luo T, Sun HY, Huang J, Tang DF, Wu L, et al. RNA interference mediated Pten knock-down inhibit the formation of polycystic ovary. Mol Cell Biochem. 2013;380(1\u20132):195\u2013202.","journal-title":"Mol Cell Biochem"},{"key":"498_CR33","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol. 2022;13:1091147.","journal-title":"Front Endocrinol"},{"issue":"4","key":"498_CR34","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s12035-021-02714-1","volume":"59","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Tu Z, Zhang J, Tan C, Shen X, Wan B, et al. Follicular Fluid-Derived Exosomal MicroRNA-18b-5p regulates PTEN-Mediated PI3K\/Akt\/mTOR signaling pathway to inhibit polycystic ovary syndrome development. Mol Neurobiol. 2022;59(4):2520\u201331.","journal-title":"Mol Neurobiol"},{"issue":"3\u20134","key":"498_CR35","first-page":"Cbm240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark A. 2024;41(3\u20134):Cbm240119.","journal-title":"Cancer Biomark A"},{"issue":"8","key":"498_CR36","doi-asserted-by":"publisher","first-page":"167454","DOI":"10.1016\/j.bbadis.2024.167454","volume":"1870","author":"MM Li","year":"2024","unstructured":"Li MM, Shi MJ, Feng CC, Yu ZY, Bai XF, Lu L. LncRNA KCNQ1OT1 promotes NLRP3 inflammasome activation in parkinson\u2019s disease by regulating pri-miR-186\/mature miR-186\/NLRP3 axis. Biochim Et Biophys Acta Mol Basis Disease. 2024;1870(8):167454.","journal-title":"Biochim Et Biophys Acta Mol Basis Disease"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00498-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:14:51Z","timestamp":1757225691000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00498-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00498-1","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of General Hospital of Central Theater Command of Chinese People\u2019s Liberation Army. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent from all participants were obtained prior to its initiation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}